About: Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • CSL, licensee of UniQuest´s HPV technology, and Aventis Pasteur MSD (a joint venture between Merck and Co and Aventis) are jointly developing a vaccine for the potential prophylaxis of genital warts and cervical cancer caused by human papilloma virus infection. Enrollment for a phase III trial has been completed
  • CSL, licensee of UniQuest´s HPV technology, and Aventis Pasteur MSD (a joint venture between Merck and Co and Aventis) are jointly developing a vaccine for the potential prophylaxis of genital warts and cervical cancer caused by human papilloma virus infection. Enrollment for a phase III trial has been completed (en)
  • CSL, nositel licence UniQuest HPV technologie, a Aventis Pasteur MSD (společný podnik Merck, Co a Aventis) společně vyvíjejí vakcínu pro potenciální profylaxi genitálních bradavic a rakoviny děložního čípku vyvolané infekcí lidským papilomavirem. Bylo ukončeno řízení pro 3. fázi klinických testů (cs)
Title
  • Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL
  • Technologické zhodnocení: HPV vakcína (kvadrivalentní), Aventis Pasteur MSD/CSL (cs)
  • Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL (en)
skos:prefLabel
  • Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL
  • Technologické zhodnocení: HPV vakcína (kvadrivalentní), Aventis Pasteur MSD/CSL (cs)
  • Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL (en)
skos:notation
  • RIV/68378050:_____/04:00105306!RIV/2005/AV0/A23005/N
http://linked.open.../vavai/riv/strany
  • 206;211
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(AV0Z5052915)
http://linked.open...iv/cisloPeriodika
  • 2
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 589725
http://linked.open...ai/riv/idVysledku
  • RIV/68378050:_____/04:00105306
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • anticancer; antiviral; vaccine (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [FE024BA479B8]
http://linked.open...i/riv/nazevZdroje
  • Current Opinion in Molecular Therapeutics
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 6
http://linked.open...iv/tvurceVysledku
  • Reiniš, Milan
http://linked.open...n/vavai/riv/zamer
issn
  • 1464-8431
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 100 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software